NEWS
May 2, 2012 | By Marie McCullough, Inquirer Staff Writer
The blood-pressure-lowering drugs known as ACE inhibitors are a mainstay of treatment for many diseases. But with growing use of these heart-helping medications, more and more patients are winding up in emergency rooms with a rare side effect that most have not been warned about: swelling around the face and neck. In the worst cases, the patient's tongue and throat become hugely bloated, closing the airway. No medications can slow or reverse this swelling, called angioedema.
NEWS
February 29, 2012 | By Harry Jackson Jr., ST. LOUIS POST-DISPATCH
ST. LOUIS - Caroll Marlow, 71, said she has been rescued from clinical depression by researchers at Washington University who want to help people older than 60. After more than 40 years of living with depression, she said, experiences and feelings that are routine for most other people are new for her. She goes to lunch to laugh with her sisters; she's closer to her children and friends. She dates her husband. And she found a job. "I love it; I work a swing shift and I just love it," she said.
BUSINESS
November 19, 2011 | By David Sell, Inquirer Staff Writer
Avastin is no longer approved for treating metastatic breast cancer because it exposes patients to dangerous side effects without any benefit, the U.S. Food and Drug Administration said Friday. The FDA noted that Avastin's risks include severely high blood pressure, bleeding, heart attacks, and perforations in such body parts as the nose, stomach, and intestines. "After reviewing the available studies it is clear that women who take Avastin for metastatic breast cancer risk potentially life-threatening side effects without proof that the use of Avastin will provide a benefit, in terms of delay in tumor growth, that would justify those risks," FDA Commissioner Margaret A. Hamburg said.
NEWS
November 8, 2011 | By Bonnie L. Cook, Inquirer Staff Writer
The Conshohocken woman found dead in the Schuylkill on Aug. 10 was being treated for narcolepsy with a controlled substance known to have serious side effects, an official said. Coroner Walter I. Hofman said last month that Catherine Kelly, 72, died from accidental drowning in the river. Earlier, he refused to name a firm cause of death until toxicology reports were received. The Montgomery County coroner said tests showed therapeutic levels of gamma hydroxybutyrate, also known as sodium oxybate, in Kelly's blood.
NEWS
August 15, 2011 | By Mitchell Hecht, For The Inquirer
Question: My husband had robotic surgery for Stage 1 prostate cancer. He can have orgasms, but he does not have erections. Will that ever change? His surgeon is evasive about it. My husband is 60 years old and I'm 50. Answer: It would be helpful for me to know when your husband had his robotic surgery, since sexual side effects often improve significantly within three to 12 months after robotic prostate-removal surgery. A significantly lower risk of permanent impotence is the biggest advantage of robotic-assisted prostate cancer surgery over the traditional radical prostate cancer surgery.
NEWS
May 6, 2011 | By Marilynn Marchione, Associated Press
Men under 65 with early prostate cancer had better survival odds if they had surgery right away instead of waiting for treatment only if their cancer got worse, a study in Sweden found. That was true even for tumors thought to be low-risk because they did not look very aggressive under a microscope. Doctors have long debated whether and how to treat such early cases, and the study shows "there clearly is a benefit to getting the cancer out in the younger population," said Richard Greenberg, urology chief at Fox Chase Cancer Center in Philadelphia.
NEWS
April 27, 2011 | ASSOCIATED PRESS
WASHINGTON - Federal health experts are recommending approval for a highly anticipated drug from Merck to treat hepatitis C, based on studies showing that it cures patients at a higher rate than drugs used for over 20 years. A Food and Drug Administration panel of experts voted unanimously, 18-0, in favor of Merck's boceprevir tablet as an effective treatment for hepatitis C, which affects an estimated 3.2 million Americans. The agency is not required to follow the group's recommendation, though it usually does.
NEWS
January 24, 2011 | By Marie McCullough, Inquirer Staff Writer
It would be insulting and inaccurate to suggest that the menopausal meltdown known as a hot flash is all in a woman's head. But the brain plays a big, rather mysterious, role. The latest evidence comes from a study of the antidepressant Lexapro led by University of Pennsylvania researcher Ellen W. Freeman. Over eight weeks, Lexapro was much better than a placebo at reducing hot flash severity and frequency among 205 women of a certain age. Lexapro improves mood by boosting the brain's supply of serotonin, a chemical messenger.
NEWS
October 26, 2010 | By Annette John-Hall, Inquirer Columnist
Three years ago, as my dear friend Gloria Harper Dickinson waged a losing battle with inflammatory breast cancer, she would constantly mention the name of Lillie Daniels. "My guardian angel," Gloria would say. That year, I met Daniels with Gloria at the annual luncheon for cancer survivors (or overcomers, as Daniels likes to say) hosted by her foundation, Bread of Life. Right away, I understood why Gloria loved her so much. See, as a cancer survivor herself, Daniels knew what Gloria was going through.
NEWS
September 3, 2010 | By Lynne Tuohy, ASSOCIATED PRESS
CONCORD, N.H. - A New Hampshire woman is seeking more than $24 million in damages from the Philadelphia-based maker of a prescription drug she took to ease shoulder pain, but that caused a reaction so severe that she is now blind and scarred by internal and external burns. A federal jury began deliberations today after a 14-day trial in the products liability lawsuit filed by Karen Bartlett, 51, of Plaistow, against Mutual Pharmaceutical Co. Mutual manufactures and distributes a generic brand of Sulindac.